Phenomics Australia’s Deputy CEO, A/Prof. Jim Hennessy, and Digital Platforms Director, Ms. Sarah Nisbet, visited Sydney’s premier research hubs at the Victor Chang Cardiac Research Institute (VCCRI) Innovation Centre.
During their visit, they toured Phenomics Australia’s Stem Cell Production Facility iPSC Reprogramming Service, where the team showcased groundbreaking technologies and revolutionary scientific advancements. These innovations span critical areas of human health, including cardiovascular disease, neurological disorders, metabolic and immune conditions, and cancer.
The visit offered an inspiring glimpse into the cutting-edge equipment and advanced technologies that are driving progress in translational medical research and extending their impact beyond the health sector. The immersive experience included insights into state-of-the-art laboratories and demonstrations of transformative research approaches, such as disease modelling, mechanism deconvolution, and validation of therapeutics research.
We extend our heartfelt gratitude to the exceptional teams at VCCRI for their warm hospitality and for providing such a dynamic showcase of their work. It was a privilege to witness the remarkable innovations emerging from these facilities, and we look forward to amplifying their achievements across our broader network.
For more information about the expertise and services available at Phenomics Australia’s In Vitro node at the VCCRI Innovation Centre, we invite you to connect with us.
Together, we’re shaping the future of health innovation.
